Inaugural edition of ‘Technology Dialogue’ by MEA at BLR

The Ministry of External Affairs announced on Thursday that it will host the inaugural edition of 'Technology...

Bengaluru industry fumes as cabinet approves job reservation bill

As the Karnataka cabinet approved a Bill that mandates private industries to hire 100 per cent Kannadigas for "C...

OCTF's guidelines for Head & Neck Cancer recognized

The OCTF's consensus guidelines were included in the journal Cancers as part of a scoping review that identified and...

"Bangalore’s shambolic state has provided enough content for...":

Reacting to the remarks made by comedian Trevor Noah on Bengaluru in an event, Founder of Biocon Limited Kiran...

Kiran Mazumdar-Shaw to retire from Infosys board

Kiran Mazumdar-Shaw was appointed to the Infosys' Board as an Independent Director in 2014, and as Lead Independent...

Indian women who found greatness through grit, courage

India's transformation and modernisation have been made possible no less by women than men. These women contributed...

Dr Devi Shetty and Kiran Mazumdar Shaw inaugurated BMT Unit

Bengaluru (Karnataka) [India], February 3 (ANI/NewsVoir): With a vision to strengthen its presence in cancer care...

Kiran Mazumdar Shaw leads investment in Gytree.com

New Delhi [India], January 11 (ANI/PNN): Gytree.com announced its first round of fundraising, led by Biocon's Kiran...

FM Sitharaman, 4 Indians on Forbes' 100 Most Powerful Women list

Forbes had placed President of the European Commission Ursula von der Leyen on the top position of the 19th annual...

Biocon Biologics appoints Shreehas Tambe as MD, CEO

Tambe takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on...

Biocon Biologics completes acquisition of Viatris

Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE...

Biocon subsidiary completes acquisition of Viatris for USD 3 bn

According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals...